Experiment 390737
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Serenoa repens (ARECACEAE) |
| Citation | SCHNEIDER,HJ: HONOLD,E: MASUHR,T:. (1995). TREATMENT OF BENIGN PROSTATIC HYPERPLASIA. RESULTS OF A SURVEILLANCE STUDY IN THE PRACTICES OF UROLOGICAL SPECIALISTS USING A COMBINED PLANT-BASED PREPARATION (SABAL EXTRACT WS 1473 AND URTICA EXTRACT WS 1031).. 113(3) |
| Amount utilized | |
| Compound isolated | |
| Disease | AN OPEN, PROSPECTIVE, MULTICENTRIC SURVEILLANCE STUDY MEASURED. THE EFFICACY AND TOLERABILITY OF A COMBINATION PREPARATION COMPRISING SABAL EXTRACT WS 1473 AND URTICA EXTRACT WS 1031 WERE INVESTIGATED IN 2080 PATIENTS WITH STAGE I OR II BENIGN PROSTATIC HYPERPLASIA (ACC. TO ALKEN). A BEFORE-AND-AFTER COMPARISON REVEALED AN IMPROVEMENT IN THE PATHOLOGICAL FINDINGS AND IN THE OBSTRUCTIVE AND IRRITATIVE SYMPTOMS. FOR THE MOST PART, THE EFFICACY AND TOLERABILITY OF THE PREPARATION WERE ASSESSED BY THE PHYSICIAN TO BE "VERY GOOD" OR "GOOD". AT THE END OF TREATMENT, MOST PATIENTS INDICATED AN IMPROVEMENT IN THEIR PROSTATIC SYMPTOMATOLOGY AND IN GENERAL QUALITY OF LIFE. FIFTEEN PATIENTS (0.72%) WERE SUSPECTED OF HAVING DEVELOPED MILD SIDE EFFECTS. |
| Dose amount | 320.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | ETHER EXT |
| Gender | MALE |